NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy ...

Responsive neurostimulation has also shown promising results, particularly in patients with idiopathic generalized epilepsy (IGE). A case series reported significant reductions in seizure ...

Understanding whether a dog is genetically inclined to have seizures can help owners take preventative measures and seek early diagnosis. Idiopathic epilepsy is the most common cause of seizures ...